What it means
Dulaglutide is made by Eli Lilly and comes in a single-dose pen. The label starts at 0.75 mg once a week and allows increases to 1.5 mg, 3 mg and 4.5 mg, each after at least 4 weeks on the prior dose.
Trulicity is approved to improve blood sugar in type 2 diabetes and to lower the risk of major heart events in adults with type 2 diabetes and heart disease or risk factors. Some people lose weight on it, but weight loss is not an approved use and average loss in trials was modest.
If you are comparing options for weight, Trulicity belongs in the conversation mainly because insurers may already cover it for diabetes. Ask your prescriber how it compares with weight-approved options for your goals.
Why it matters
Knowing dulaglutide is a diabetes drug first helps set fair expectations in comparison pages.
Related terms
Clinician review pending. Drafted from primary sources and waiting for sign-off by a licensed clinician (MD, DO or PharmD) before launch. Every number is checked against its source. Drug facts are re-checked quarterly, prices monthly and whenever a label changes. How we review · Report an error